Results 161 to 170 of about 327,362 (360)
ESC Heart Failure, Volume 12, Issue 2, Page 1166-1175, April 2025.A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu +10 more
wiley +1 more source
Concomitant replacement of the ascending aorta in aortic valve replacement—better safe than sorry? [PDF]
, 2021 Julia Dumfarth +2 more
openalex +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk +12 more
wiley +1 more source
An aortic root abscess in a patient with a bicuspid aortic valve: a case report [PDF]
, 2020 Elyse Balzan, Alexander Borg
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source
P114 NO CONTRAST APPROACH FOR TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH SEVERE RENAL DISFUNCTION [PDF]
, 2023 G Pignatelli +5 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies +23 more
wiley +1 more source
The Journal of ExtraCorporeal Technology, 1990 Indications for aortic valve replacement can be summarized into two disease processes, moderate to severe aortic stenosis (with or without symptoms) and moderate to severe aortic insufficiency. Fortunately, standards of care differ with each physician and so indications for aortic valve replacement are not clearly defined. To understand how the surgeon
openaire +2 more sources